At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PTIX Protagenic Therapeutics Inc
Pre-Market Trading 12-24 07:52:17 EST
0.5346
-0.0655
-10.91%
盘前0.5210
-0.0136-2.54%
07:38 EST
High0.7999
Low0.5202
Vol1.79M
Open0.7138
D1 Closing0.6001
Amplitude46.61%
Mkt Cap3.63M
Tradable Cap2.98M
Total Shares6.79M
T/O1.18M
T/O Rate32.11%
Tradable Shares5.58M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Protagenic Therapeutics Files Prospectus for Shares Sale by Stockholders
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.